Need a specific person's email?
Browse The Cancer Letter's employee directory (about 12 employees) and reveal verified emails free.
The Cancer Letter's most common email format is First@cancerletter.com (ex. John@cancerletter.com), used for 100% of cancerletter.com addresses. The Cancer Letter uses 1 email pattern.
| Format | Example | Share of cancerletter.com |
|---|---|---|
| First@cancerletter.comMost common | John@cancerletter.com |
Browse The Cancer Letter's employee directory (about 12 employees) and reveal verified emails free.
Newspaper PublishingDistrict of Columbia, United States11-50 Employees
The Cancer Letter is an independent weekly newspaper based in Washington, DC, focusing on oncology and related policy, regulation, and funding issues since 1973. It provides in-depth coverage of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health, with emphasis on institutions such as the National Cancer Institute, NIH, FDA, Congress, cancer centers, and the pharmaceutical industry. Its readership includes leaders at academic centers, community oncology practices, government agencies, professional associations, health IT and industry players, investors, and advocacy groups, reflecting its role as a key source of information for stakeholders shaping oncology and related policy. The publication is recognized for investigative reporting and has received coverage and influence across major outlets and institutions; its reporting has spurred inquiries and actions by government and regulatory bodies. The Cancer Letter is part of the broader newspaper publishing sector and operates in the Washington, DC area, with recent activity highlighting recognition in the Webby Awards related to its podcast and ongoing projects such as the Cancer History Project.
Most common format
First@cancerletter.com
Example: John@cancerletter.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.